 |
|
Phase III Randomized Study of Adjuvant Tegafur-Uracil Versus Observation Only in Patients With Curatively Resected Stage II Colorectal Cancer
Alternate Title Basic Trial Information Objectives Entry Criteria Expected Enrollment Outcomes Outline Trial Contact Information Registry Information
Alternate Title
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
Basic Trial Information
 |
Phase
 |
 |
 |
 |
Type
 |
 |
 |
 |
Status
 |
 |
 |
 |
Age
 |
 |
 |
 |
Sponsor
 |
 |
 |
 |
Protocol IDs
 |
 |
 |
 |

Phase III

|
 |
 |
 |

Treatment

|
 |
 |
 |

Active

|
 |
 |
 |

20 to 80

|
 |
 |
 |

Other

|
 |
 |
 |

TMDU-BRI-CC-05-01 NCT00392899

|
 |
|
Objectives Primary - Compare the efficacy of adjuvant tegafur-uracil vs observation only in patients with curatively resected stage II colorectal cancer.
Secondary - Compare relapse-free and overall survival of patients treated with these regimens.
- Compare the occurrence of adverse events in patients treated with these regimens.
Entry Criteria Disease Characteristics:
- Histologically confirmed adenocarcinoma of the colon or rectosigmoid
- Has undergone curative (R0) resection within the past 8 weeks
- No suspicion of hereditary colorectal cancer
- No severe postoperative complications
Prior/Concurrent Therapy:
- See Disease Characteristics
- No prior chemotherapy
- No prior or concurrent radiotherapy
- No concurrent prophylactic growth factors
- No concurrent biologic response modifiers
Patient Characteristics:
- ECOG performance status 0-1
- WBC 3,500-12,000/mm³
- Absolute neutrophil count ≥ 1,500/mm³
- Platelet count ≥ 100,000/mm³
- Hemoglobin ≥ 9.0 g/dL
- Bilirubin ≤ 2.0 mg/dL
- AST and ALT ≤ 100 IU/L
- Creatinine ≤ 1.5 mg/dL
- Not pregnant or nursing
- Able to take oral medications
- Major organ functions are preserved
- No other active malignancy
- None of the following conditions:
- Uncontrolled diabetes mellitus
- Uncontrolled hypertension
- Myocardial infarction or unstable angina pectoris within the past 6 months
- Liver cirrhosis
- Interstitial pneumonia
- Pulmonary fibrosis
- Severe emphysema
- No psychiatric disease or other condition that would preclude study participation
Expected Enrollment 2000A total of 2,000 patients will be accrued for this study. Outcomes Primary Outcome(s)Disease-free survival
Secondary Outcome(s)Relapse-free survival Overall survival Adverse events
Outline This is a randomized, controlled study. Patients are randomized to 1 of 2 treatment arms. - Arm I: Patients undergo observation.
- Arm II: Patients receive oral tegafur-uracil on days 1-5. Treatment repeats every 7 days for 1 year in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed periodically for 5 years.
Trial Contact Information
Trial Lead Organizations Tokyo Medical and Dental University  |  |  | | Kenichi Sugihara, MD, Protocol chair |  | |  | Trial Sites
 |
 |
 |
 |
| Japan |
 |
| Aichi |
 |
| |
Aichi-gun |
 |
| | | | | Aichi Medical University |
| | | Toshiaki Nonami, MD | |
|
| |
Nagoya |
 |
| | | Aichi Cancer Center |
| | | Takashi Hirai, MD | |
| | Email:
thirai@aichi-cc.jp |
| | | Nagoya Ekisaikai Hospital |
| | | Hiroshi Kohno, MD | |
| | | Nagoya University Hospital |
| | | Yasuhiro Kodera, MD | |
| | Email:
ykodera@med.nagoya-u.ac.jp |
| | | Nagoya University School of Medicine |
| | | Norihiko Yuasa, MD, PhD | |
|
| |
Nagoya-shi |
 |
| | | Japanese Red Cross Nagoya First Hospital |
| | | Eiji Takeuchi, MD | |
| | | Nagoya City University Hospital |
| | | Hiromitsu Takeyama, MD | |
|
| |
Toyohashi |
 |
| | | National Hospital Organization Toyohashi Medical Center |
| | | Tooru Ichihara, MD, PhD | |
|
| |
Toyota |
 |
| | | Koseiren Kamo Hospital |
| | | Junichi Kamiya, MD, PhD | |
|
| Akita |
 |
| |
Akita |
 |
| | | | Akita Kumiai General Hospital |
| | | Kazuhiko Endo, MD | |
|
| Chiba |
 |
| |
Asahi-machi |
 |
| | | | Asahi General Hospital |
| | | Nobutaka Tanaka, MD, PhD | |
|
| |
Inba-gunn |
 |
| | | Nippon Medical School |
| | | Noritake Tanaka, PhD | |
|
| |
Urayasu-shi |
 |
| | | Juntendo Urayasu Hospital |
| | | Masaki Fukunaga, MD, PhD | |
| | Email:
masaki-f@juntendo-urayasui.jp |
|
| Ehime |
 |
| |
Niihama-shi |
 |
| | | | Sumitomo Besshi Hospital |
| | | Hideyuki Saeki, MD | |
|
| Fukui |
 |
| |
Fukui-shi |
 |
| | | | Fukuiken Saiseikai Hospital |
| | | Yoshinori Munemoto, MD | |
|
| |
Yoshida-gun |
 |
| | | University of Fukui Hospital |
| | | Akio Yamaguchi, MD, PhD | |
| | Email:
akio@u-fukui.ac.jp |
|
| Fukuoka |
 |
| |
Fukuoka |
 |
| | | | National Kyushu Cancer Center |
| | | Yasushi Toh, MD, PhD | |
|
| |
Fukuoka-shi |
 |
| | | Kyushu University Hospital |
| | | Yoshihiko Maehara, MD, PhD | |
|
| |
Kitakyushu-shi |
 |
| | | Kitakyushu Municipal Medical Center |
| | | Hiroyuki Konomi, MD, PhD | |
| | | University of Occupational and Environmental Health |
| | | Naoki Nagata, MD | |
|
| |
Kurume |
 |
| | | Kurume University School of Medicine |
| | | Kazuo Shirouzu, MD, PhD | |
| | Email:
skazuo@med.kurume-u.ac.jp |
| | | Saint Mary's Hospital |
| | | Satoshi Taniwaki, MD | |
|
| |
Tagawa-shi |
 |
| | | Social Insurance Tagawa Hospital |
| | | Takaho Tanaka, MD, PhD | |
|
| Fukushima |
 |
| |
Fukushima-shi |
 |
| | | | Fukushima Medical University Hospital |
| | | Shinji Ohki, MD, PhD | |
|
| Gifu |
 |
| |
Gifu-shi |
 |
| | | | Gifu Municipal Hospital |
| | | Hiroo Oshita, MD | |
|
| |
Hashima |
 |
| | | Hashima City Hospital |
| | | Mikio Yasumura, MD, PhD | |
|
| |
Ogaki-shi |
 |
| | | Ogaki Municipal Hospital |
| | | Masatoshi Isogai, MD, PhD | |
|
| Gunma |
 |
| |
Maebashi-shi |
 |
| | | | Gunma University Graduate School of Medicine |
| | | Hiroyuki Kuwano, MD, PhD | |
| | Email:
hkuwano@med.gunma-u.ac.jp |
|
| |
Otashi |
 |
| | | Gunma Cancer Center |
| | | Shinichi Sameshima, MD, PhD | |
|
| Hiroshima |
 |
| |
Fukuyama |
 |
| | | | National Hospital Organization Fukuyama Medical Center |
| | | Sadanori Fuchimoto, MD, PhD | |
|
| |
Hiroshima |
 |
| | | Hiroshima Prefectural Hospital |
| | | Hiroyuki Egi, MD | |
|
| |
Kure |
 |
| | | National Hospital Organization Kure Medical Center |
| | | Masato Koseki, MD | |
|
| Hokkaido |
 |
| |
Asahikawa |
 |
| | | | Asahikawa Medical College |
| | | Toru Kono, MD | |
| | | Otaru Ekisaikai Hospital |
| | | Kazuaki Sasaki, MD, PhD | |
|
| |
Hakodate |
 |
| | | Hakodate Goryoukaku Hospital |
| | | Akinori Takagane, MD | |
|
| |
Otaru-shi |
 |
| | | Hirosaki University, School of Medicine |
| | | Akihiko Murata, MD | |
|
| |
Sapporo |
 |
| | | Hokkaido University Graduate School of Medicine |
| | | Satoshi Kondo, MD | |
| | | Sapporo Medical University |
| | | Tomohisa Furuhata, MD | |
|
| |
Sapporo-shi |
 |
| | | Sapporo-Kosei General Hospital |
| | | Yukifumi Kondo, MD, PhD | |
|
| Hyogo |
 |
| |
Akashi |
 |
| | | | Akashi Municipal Hospital |
| | | Youichi Kadotani, MD | |
| | | Hyogo Cancer Center |
| | | Takeshi Nakamura, MD | |
|
| |
Akou |
 |
| | | Ako City Hospital |
| | | Tadashi Yokoyama, MD | |
|
| |
Amagasaki |
 |
| | | Hyogo Prefectural Amagasaki Hospital |
| | | Hisashi Shinohara, MD | |
| | | Kansai Rosai Hospital |
| | | Naohiro Tomita, MD, PhD | |
|
| |
Himeji |
 |
| | | Himeji Central Hospital |
| | | Yoshinori Munemoto, MD | |
|
| |
Kobe |
 |
| | | Kobe Medical Center |
| | | Etsuji Shimada, MD | |
| | | Kobe University Hospital |
| | | Takashi Kamigaki, MD | |
| | | Kobe West City Hospital |
| | | Mitsuo Yamamoto, MD | |
| | Email:
mitsuo-yamamoto@kobe-nishishimin-hospi.jp |
|
| |
Kobe-shi |
 |
| | | Kobe City General Hospital |
| | | Noriyuki Okada, MD, PhD | |
| | | Shakai Hoken Kobe Central Hospital |
| | | Atsushi Oguro, MD | |
|
| |
Takarazukai |
 |
| | | Higashi Takarazuka Satoh Hospital |
| | | Atsushi Ohkawa, MD | |
|
| Ibaraki |
 |
| |
Tsuchiura |
 |
| | | | Tsuchiura Kyodo General Hospital |
| | | Susumu Hiranuma, MD | |
|
| Ishikawa |
 |
| |
Kahoku-gun |
 |
| | | | Kanazawa Medical University |
| | | Shigeki Takashima, MD | |
|
| Iwate |
 |
| |
Morioka |
 |
| | | | Iwate Medical University Hospital |
| | | Go Wakabayashi, MD | |
|
| Kagawa |
 |
| |
Takamatsu |
 |
| | | | Kagawa Prefectural Central Hospital |
| | | Ichio Suzuka, MD | |
|
| Kanagawa |
 |
| |
Ashigarakami-gun |
 |
| | | | Kanagawa Prefectural Ashigawa-kami Hospital |
| | | Yuji Yamamoto, MD, PhD | |
|
| |
Fujisawa-shi |
 |
| | | Fujisawa City Hospital |
| | | Akira Nakano, MD | |
|
| |
Kanagawa |
 |
| | | Kitasato University School of Medicine |
| | | Masahiko Watanabe, MD, PhD | |
|
| |
Kawasaki |
 |
| | | Kanto Rosai Hospital |
| | | Masahiro Ishimaru, MD | | Ph: | 81-44-411-3131 ext. 8101 | | |
|
| | | Nippon Medical School Musashikosugi Hospital |
| | | Tetsuro Matsunobu, MD, PhD | |
|
| |
Sagamihara |
 |
| | | Sagamihara National Hospital |
| | | Yasuhiko Nishiyama, MD | |
|
| |
Yokohama |
 |
| | | Kanagawa Cancer Center |
| | | Makoto Akaike, MD | |
| | | Yokohama City University Medical Center |
| | | Shoichi Fujii, MD | |
| | Email:
u0970047@urahp.yokohama-cu.ac.jp |
|
| |
Yokohama-shi |
 |
| | | Saiseikai Yokohama City Nanbu Hospital |
| | | Hideyuki Ike, MD, PhD | |
| | | Showa University Northern Yokohama Hospital |
| | | Shinei Kudo, MD, PhD | |
|
| |
Yokosuka-shi |
 |
| | | Yokosuka Kyosai Hospital |
| | | Kaoru Nagahori, MD, PhD | |
| | Email:
nagakkr@yahoo.co.jp |
|
| Kochi |
 |
| |
Kochi |
 |
| | | | Kochi Health Sciences Center |
| | | Akihito Tsuji, MD, PhD | |
|
| |
Nankoku |
 |
| | | Kochi Medical School |
| | | Michiya Kobayashi, MD, PhD | |
|
| Kumamoto |
 |
| |
Yashiro |
 |
| | | | Japan Labor Health and Welfare Organization Kumamoto Rosai Hospital |
| | | Katsuhiko Inoue, MD | |
|
| Kyoto |
 |
| |
Higashiyama-ku |
 |
| | | | Kyoto First Red Cross Hospital |
| | | Hideaki Kurioka, MD | |
|
| |
Kanigyou-ku |
 |
| | | Kyoto Second Red Cross Hospital |
| | | Hitoshi Izumi, MD | |
|
| |
Sakyo-ku |
 |
| | | Kyoto University Hospital |
| | | Satoshi Nagayama, MD, PhD | |
|
| Mie |
 |
| |
Thu-shi |
 |
| | | | Mie University Graduate School of Medicine |
| | | Yashuhiro Inoue, MD, PhD | | Ph: | 81-59-232-1111 ext. 5645 | | |
|
|
| Miyagi |
 |
| |
Natori-shi |
 |
| | | | Miyagi Cancer Center |
| | | Kenichi Shiiba, MD | |
|
| |
Sendai-shi |
 |
| | | Sendai Medical Center |
| | | Toshihiro Saito, MD | |
| | | Tohoku Rosai Hospital |
| | | Hiroaki Musha, MD | |
|
| Nagano |
 |
| |
Komagane-shi |
 |
| | | | Showa-Inan General Hospital |
| | | Ken Hayashi, MD | |
|
| |
Nagano-shi |
 |
| | | Nagano Municipal Hospital |
| | | Yasuhiro Munakata, MD | |
|
| |
Nakano |
 |
| | | Hokushin Hospital |
| | | Kiyofumi Yamagishi, MD | |
|
| Nagasaki |
 |
| |
Magasaki-shi |
 |
| | | | Nagasaki University Hospital of Medicine and Dentistry |
| | | Masashi Haraguchi, MD, PhD | |
|
| |
Nagasaki-shi |
 |
| | | Japanese Red Cross Nagasaki Genbaku Hospital |
| | | Takazaki Nakazaki, MD | |
|
| |
Omura |
 |
| | | National Hospital Organization Nagasaki Medical Center |
| | | Kousei Miyashita, MD, PhD | |
|
| |
Sasebo-shi |
 |
| | | Sasebo City General Hospital |
| | | Hiroshi Ishikawa, MD | |
|
| Niigata |
 |
| |
Nagaoka |
 |
| | | | Nagaoka Chuo General Hospital |
| | | Atsushi Nishimura, MD | |
|
| |
Niigata-shi |
 |
| | | Niigata Cancer Center Hospital |
| | | Yasumasa Takii, MD | | |